F7 and COVID-19: Rise of angiotensin II levels enhances immunothrombosis with cytokine release, leukocyte and platelet recruitment, and endothelium activation leading to factor VII and PAI-1 release with positive feedback loop.[28] Immunothrombosis and the angiotensin II pathway leading to thrombosis in COVID-19 are summarized in the Figure 5.